Wolf, P <br/><br/>
Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes.  [electronic resource] 

 -  Nutrition, metabolism, and cardiovascular diseases : NMCD  05 2016 
 - 387-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1590-3729 
<br/><br/><label>Standard No.: </label>10.1016/j.numecd.2016.03.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--drug effects<br/>Aged<br/>Austria<br/>Biomarkers--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Diabetic Cardiomyopathies--blood<br/>Down-Regulation<br/>Energy Metabolism--drug effects<br/>Fatty Acids, Nonesterified--blood<br/>Female<br/>Humans<br/>Hypolipidemic Agents--adverse effects<br/>Lipolysis--drug effects<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Myocardium--metabolism<br/>Proton Magnetic Resonance Spectroscopy<br/>Pyrazines--adverse effects<br/>Risk Factors<br/>Single-Blind Method<br/>Stroke Volume--drug effects<br/>Systole<br/>Time Factors<br/>Treatment Outcome<br/>Ventricular Function, Left--drug effects